Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 17, 2021
Total Value: $2.667B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | FIVE PRIME THERAPEUTICS INC | 6,338,678 | $239M | 9.0% | — | — | COM | 33830X104 |
| OLMA | OLEMA PHARMACEUTICALS INC | 6,661,503 | $221M | 8.3% | — | — | COM | 68062P106 |
| — | MERUS N V | 7,285,071 | $152M | 5.7% | — | — | COM | N5749R100 |
| XOMA | XOMA CORP DEL | 3,530,543 | $144M | 5.4% | — | — | COM NEW | 98419J206 |
| RVMD | REVOLUTION MEDICINES INC | 2,943,049 | $135M | 5.1% | — | — | COM | 76155X100 |
| — | REPARE THERAPEUTICS INC | 3,722,398 | $114M | 4.3% | — | — | COM | 760273102 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 3,959,451 | $103M | 3.8% | — | — | COM | 74366E102 |
| KYMR | KYMERA THERAPEUTICS INC | 2,630,658 | $102M | 3.8% | — | — | COM | 501575104 |
| RLAY | RELAY THERAPEUTICS INC | 2,873,147 | $99.33M | 3.7% | — | — | COM | 75943R102 |
| ARGX | ARGENX SE | 309,599 | $85.26M | 3.2% | — | — | SPONSORED ADR | 04016X101 |
| — | ESSA PHARMA INC | 2,908,326 | $84.49M | 3.2% | — | — | COM NEW | 29668H708 |
| XENE | XENON PHARMACEUTICALS INC | 3,481,778 | $62.32M | 2.3% | — | — | COM | 98420N105 |
| IONS | IONIS PHARMACEUTICALS INC | 1,364,461 | $61.35M | 2.3% | — | — | COM | 462222100 |
| IDYA | IDEAYA BIOSCIENCES INC | 2,607,969 | $61.29M | 2.3% | — | — | COM | 45166A102 |
| ACIU | AC IMMUNE SA | 7,504,579 | $57.11M | 2.1% | — | — | SHS | H00263105 |
| RCUS | ARCUS BIOSCIENCES INC | 1,876,122 | $52.68M | 2.0% | — | — | COM | 03969F109 |
| LXRX | LEXICON PHARMACEUTICALS INC | 8,394,000 | $49.27M | 1.8% | — | — | COM NEW | 528872302 |
| KURA | KURA ONCOLOGY INC | 1,635,112 | $46.23M | 1.7% | — | — | COM | 50127T109 |
| — | IKENA ONCOLOGY INC | 1,599,658 | $45.19M | 1.7% | — | — | COM | 45175G108 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 1,031,070 | $44.73M | 1.7% | — | — | COM | 35104E100 |
| CGEM | CULLINAN ONCOLOGY INC | 1,049,356 | $43.73M | 1.6% | — | — | COM | 230031106 |
| CTMX | CYTOMX THERAPEUTICS INC | 5,576,471 | $43.11M | 1.6% | — | — | COM | 23284F105 |
| — | MOLECULAR TEMPLATES INC | 2,864,299 | $36.15M | 1.4% | — | — | COM | 608550109 |
| SPRO | SPERO THERAPEUTICS INC | 2,137,978 | $31.47M | 1.2% | — | — | COM | 84833T103 |
| — | GLYCOMIMETICS INC | 9,544,262 | $28.73M | 1.1% | — | — | COM | 38000Q102 |
| — | VIRACTA THERAPEUTICS INC | 3,094,174 | $28.62M | 1.1% | — | — | COM | 92765F108 |
| — | VERASTEM INC | 11,480,994 | $28.36M | 1.1% | — | — | COM | 92337C104 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 8,383,645 | $27.08M | 1.0% | — | — | COM | 45665G303 |
| OVID | OVID THERAPEUTICS INC | 6,417,551 | $25.8M | 1.0% | — | — | COM | 690469101 |
| ANAB | ANAPTYSBIO INC | 1,189,500 | $25.63M | 1.0% | — | — | COM | 032724106 |
| — | FORTE BIOSCIENCES INC | 718,788 | $24.63M | 0.9% | — | — | COM | 34962G109 |
| — | CALLIDITAS THERAPEUTICS AB | 750,000 | $20.72M | 0.8% | — | — | SPONSERED ADS | 13124Q106 |
| — | CTI BIOPHARMA CORP | 6,929,690 | $20.16M | 0.8% | — | — | COM | 12648L601 |
| — | SUTRO BIOPHARMA INC | 826,825 | $18.82M | 0.7% | — | — | COM | 869367102 |
| IMVT | IMMUNOVANT INC | 1,144,016 | $18.35M | 0.7% | — | — | COM | 45258J102 |
| — | CONTRAFECT CORP | 3,812,300 | $18.3M | 0.7% | — | — | COM NEW | 212326300 |
| — | GRITSTONE ONCOLOGY INC | 1,861,239 | $17.55M | 0.7% | — | — | COM | 39868T105 |
| SLN | SILENCE THERAPEUTICS PLC | 666,666 | $15.82M | 0.6% | — | — | ADS | 82686Q101 |
| — | ANGION BIOMEDICA CORP | 875,000 | $15.81M | 0.6% | — | — | COM | 03476J107 |
| — | PIERIS PHARMACEUTICALS INC | 5,494,582 | $14.12M | 0.5% | — | — | COM | 720795103 |
| REPL | REPLIMUNE GROUP INC | 461,428 | $14.08M | 0.5% | — | — | COM | 76029N106 |
| — | CALITHERA BIOSCIENCES INC | 5,566,690 | $13.47M | 0.5% | — | — | COM | 13089P101 |
| COGT | UNUM THERAPEUTICS INC | 1,532,282 | $13.45M | 0.5% | — | — | COM | 19240Q201 |
| — | MEI PHARMA INC | 3,588,155 | $12.31M | 0.5% | — | — | COM NEW | 55279B202 |
| ELDN | ELEDON PHARMACEUTICALS INC | 1,113,435 | $11.91M | 0.4% | — | — | COM | 28617K101 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 4,012,404 | $10.87M | 0.4% | — | — | COM NEW | 372427401 |
| — | SELECTA BIOSCIENCES INC | 2,379,986 | $10.77M | 0.4% | — | — | COM | 816212104 |
| — | AMARIN CORP PLC | 1,715,981 | $10.66M | 0.4% | — | — | SPONS ADR NEW | 023111206 |
| — | CIDARA THERAPEUTICS INC | 3,739,704 | $9.948M | 0.4% | — | — | COM | 171757107 |
| CRVS | CORVUS PHARMACEUTICALS INC | 3,229,426 | $9.947M | 0.4% | — | — | COM | 221015100 |
| — | X4 PHARMACEUTICALS INC | 1,091,579 | $9.398M | 0.4% | — | — | COM | 98420X103 |
| — | BCTG ACQUISITION CORP | 800,000 | $8.896M | 0.3% | — | — | COM | 05492W103 |
| — | THERAPEUTICS ACQUISITION COR | 772,226 | $8.116M | 0.3% | — | — | COM CL A | 88339T103 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 463,504 | $7.745M | 0.3% | — | — | COM | 92790C104 |
| — | AILERON THERAPEUTICS INC | 5,265,555 | $7.53M | 0.3% | — | — | COM | 00887A105 |
| — | GALMED PHARMACEUTICALS LTD | 1,799,694 | $6.173M | 0.2% | — | — | SHS | M47238106 |
| — | RESEARCH ALLIANCE CORP II | 500,000 | $5.125M | 0.2% | — | — | COM CL A | 760873109 |
| — | FRAZIER LIFESCIENCES ACQU CO | 500,000 | $5.105M | 0.2% | — | — | UNIT 12/09/2025 | G3710A121 |
| — | EUCRATES BIOMEDICAL ACQU COR | 500,000 | $5.03M | 0.2% | — | — | UNIT 10/23/2027 | G3141W114 |
| — | 5 01 ACQUISITION CORP | 500,000 | $4.975M | 0.2% | — | — | COM CL A | 33836P105 |
| — | ERYTECH PHARMA | 625,000 | $4.469M | 0.2% | — | — | SPONSORED ADR | 29604W108 |
| — | FORWARD PHARMA A/S | 647,299 | $4.434M | 0.2% | — | — | SPONSORD ADS NEW | 34986J204 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 163,524 | $3.656M | 0.1% | — | — | COM | 87164F105 |
| — | JIYA ACQUISITION CORP | 300,000 | $2.952M | 0.1% | — | — | COM CL A | 47760M102 |
| IVA | INVENTIVA SA | 107,000 | $1.573M | 0.1% | — | — | ADS | 46124U107 |
| RZLT | REZOLUTE INC | 190,815 | $1.347M | 0.1% | — | — | COM NEW | 76200L309 |
| — | LIFESCI ACQUISITION II CORP | 100,000 | $1.014M | 0.0% | — | — | COM | 53229E103 |